Functional cardiac consequences of β-adrenergic stress-induced injury in a model of Duchenne muscular dystrophy
Disease Models & Mechanisms · 2024
DOI: 10.1242/dmm.050852 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2024. Verfasst von Conner C Earl und 5 weiteren Autor:innen. Beteiligte Einrichtung: Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN 47907, USA. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Mice, Inbred mdx, Isoproterenol, Disease Models, Animal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indiana University School of Medicine and Purdue University College of Engineering in Medicine Pilot Project Initiative, Purdue University, NIAMS NIH HHS.
Abstract (Originalsprache)
Cardiomyopathy is the leading cause of death in Duchenne muscular dystrophy (DMD); however, in the mdx mouse model of DMD, the cardiac phenotype differs from that seen in DMD-associated cardiomyopathy. Although some have used pharmacologic stress to stimulate injury and enhance cardiac pathology in the mdx model, many methods lead to high mortality with variable cardiac outcomes, and do not recapitulate the structural and functional cardiac changes seen in human disease. Here, we describe a simple and effective method to enhance the cardiac phenotype model in mdx mice using advanced 2D and 4D high-frequency ultrasound to monitor cardiac dysfunction progression in vivo. mdx and wild-type mice received daily low-dose (2 mg/kg/day) isoproterenol injections for 10 days. Histopathological assessment showed that isoproterenol treatment increased myocyte injury, elevated serum cardiac troponin I levels and enhanced fibrosis in mdx mice. Ultrasound revealed reduced ventricular function, decreased wall thickness, increased volumes and diminished cardiac reserve in mdx compared to wild-type mice. Our findings highlight the utility of challenging mdx mice with low-dose isoproterenol as a valuable model for exploring therapies targeting DMD-associated cardiac pathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN 47907, USA.
- Department of Medicine, Indiana University School of Medicine, IN 46202, USA.
- Musculoskeletal Health Sciences Program, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Division of Pediatric Cardiology, Riley Children's Hospital at Indiana University Health, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Indiana Center for Musculoskeletal Health, Indianapolis, IN 46202, USA.
ORCID-Profile: Conner C Earl, Areli J Javier, Larry W Markham, Craig J Goergen, Steven S Welc
Förderung
- Indiana University School of Medicine and Purdue University College of Engineering in Medicine Pilot Project Initiative
- Purdue University
- NIAMS NIH HHS
- NHLBI NIH HHS
- Indiana University
- Indiana University-Purdue University Indianapolis
- Riley Children's Foundation
- National Heart, Lung, and Blood Institute
Zitieren
APA
Earl, C. C., Javier, A. J., Richards, A. M., Markham, L. W., Goergen, C. J., & Welc, S. S. (2024). Functional cardiac consequences of β-adrenergic stress-induced injury in a model of Duchenne muscular dystrophy. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.050852
Vancouver
Earl CC, Javier AJ, Richards AM, Markham LW, Goergen CJ, Welc SS. Functional cardiac consequences of β-adrenergic stress-induced injury in a model of Duchenne muscular dystrophy. Disease Models & Mechanisms. 2024. doi:10.1242/dmm.050852
BibTeX
@article{Earl2024,
author = {Earl, Conner C and Javier, Areli J and Richards, Alyssa M and Markham, Larry W and Goergen, Craig J and Welc, Steven S},
title = {Functional cardiac consequences of β-adrenergic stress-induced injury in a model of Duchenne muscular dystrophy},
journal = {Disease Models & Mechanisms},
year = {2024},
doi = {10.1242/dmm.050852}
}
EUVIMED